TextMed
TextMap   :   TextMed   :   Textblg   :   TextBiz   :   Make homepage!   :   Link to us   :   Help?
Tirofiban   |   Unknown


Relational Network
Reference Time Series
References Per Million vs. Moving Average
News Sector Distribution
Reference Share by Type News vs. Business vs. Entertainment vs. Sports vs. Other
Sentiment Analysis
Polarity Ranks vs. Subjectivity Ranks
Juxtapositions for Tirofiban
NameCoref./Ref.
IIb/IIIa
eptifibatide
Outcomes
Randomized Efficacy Study
myocardial infarction
Abciximab
Heatmap
Juxtapositions for Tirofiban:

Historic (1865-12-01 to 2009-12-20)
Rank Entity Name Count Score Coref./Ref.
1 IIb/IIIa 20 230.4
2 eptifibatide 14 181.5
3 Outcomes 12 160.3
4 Randomized Efficacy Study 10 147.4
5 myocardial infarction 14 115.0
6 Abciximab 8 114.6
7 Restenosis 8 114.0
8 acute coronary syndrome 8 111.3
9 liposomes/chitosan scaffold/human fibrin gel composite system 7 105.3
10 nonpeptide 7 93.7
11 Cypher DES 6 93.5
12 GPIIb/IIIa 7 90.5
13 thrombus 8 90.4
14 percutaneous coronary intervention 8 89.0
15 aspirin 8 85.0
10 years (1999-12-23 to 2009-12-20)
Rank Entity Name Count Score Coref./Ref.
1 eptifibatide 14 170.5
2 IIb/IIIa 14 153.5
3 acute coronary syndrome 8 105.0
4 liposomes/chitosan scaffold/human fibrin gel composite system 7 99.8
5 Cypher DES 6 88.8
6 thrombus 8 84.1
7 percutaneous coronary intervention 8 82.8
8 Abciximab 6 81.6
9 Outcomes 6 77.2
10 myocardial infarction 10 75.3
11 Facilitated Angioplasty 5 73.2
12 Myocardial Infarction 6 72.0
13 GP IIb/IIIa 5 61.2
14 Facilitated Angioplasty with Tirofiban or Abciximab 4 60.8
15 Randomized Efficacy Study 4 60.8
365 days (2008-12-20 to 2009-12-20)
Rank Entity Name Count Score Coref./Ref.
1 Abciximab 4 48.8
2 Facilitated Angioplasty 4 48.8
3 Facilitated Angioplasty with Tirofiban or Abciximab 4 48.8
4 percutaneous coronary intervention 4 30.5
5 Myocardial Infarction 3 26.2
6 P-selectin 3 25.6
7 On-TIME 2 23.3
8 nonpeptide 2 23.3
9 rats 3 17.0
10 Left Ventricular Function After ST-Elevation 1 12.2
11 Percutaneous Coronary Intervention 1 12.2
12 Platelet Glycoprotein Receptor Inhibitors 1 11.6
13 ST-elevation 1 9.9
14 vascular smooth muscle cells 1 8.8
15 90 days 1 8.7
Popularity Time Series:

References Per Million vs. Moving Average (log|linear)

Reference Share by Type News vs. Business vs. Entertainment vs. Sports vs. Other
Sentiment Analysis for Tirofiban:

Polarity Ranks vs. Subjectivity Ranks
Positive Raw Counts vs. Negative Raw Counts (log|linear)
Where is Tirofiban HOT?:


Relational Network:


Also known as: tirofiban, Tirofiban, TIrofiban.
Generated on 17th September 2009 16:32
About TextMed   :   Research Papers   :   TextMed Team   :   Disclaimer   :   Contact Us   :   TextMap Blog   :   General Sentiment
Copyright (c) 2009 The Research Foundation of State University of New York
Computer Science Department at Stony Brook University
Weblog Crawler Powered by Spinn3r